Episteme’s Regulatory team offers expert guidance and submission support throughout the entire product development and launch process. With over 100 years of cumulative experience, we meticulously plan and coordinate every aspect of a clear and complete submission. Our extensive regulatory and scientific expertise, allows us to optimize the submission process. We provide consulting services for key regulatory submissions for US, EU, CA and AUS including:
Investigational New Drug Applications (INDs): Support for pre-IND meetings, preparation, and submission.
New Drug Applications (NDAs) and Assistance throughout the preparation, submission, and review to ensure timely approvals.
Abbreviated New Drug Applications (ANDAs): Expertise in generic drug submissions, bioequivalence studies requirements, and Labeling Reviews, Regulatory Strategy Development: Customized strategies to navigate regulatory pathways and mitigate risks.
Post-Approval Compliance: Ongoing support for maintaining compliance with the post-marketing requirements.
Our deep knowledge help streamline the regulatory process, ensuring your product reaches the market efficiently. Whether in early development or preparing for launch, Episteme’s Regulatory team is here to provide the expertise and support you need for success.

EPISTEME PHARMA

Org chart

Teams

Offices